STOCK TITAN

AstroNova, Inc. (ALOT) Financials

ALOT
Trailing 12 months to April 30, 2026
Revenue $152.2M YoY not available
Net Income -$1.3M YoY not available
EPS (Diluted) -$0.18 YoY not available
Free Cash Flow $10.1M YoY not available
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Apr 30, 2026 Reported Currency USD FYE January

Newest figures come from the 10-Q for Q1 FY2027, filed Jun 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ALOT SEC filings page.

AstroNova, Inc. (ALOT) reported $152.2M in revenue over the twelve months to Apr 30, 2026. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ALOT FY2026

AstroNova’s cash generation recovered before earnings, while flat sales and thinner margins leave the business near operating breakeven.

The gap between a net loss of $2.4M and operating cash flow of $11.7M indicates cash conversion was driven by noncash costs and working-capital release rather than reported earnings. With free cash flow of $11.4M alongside only $332K of capital spending, FY2026 was a low-reinvestment cash year, not evidence of durable earnings strength.

The move from -5.7% in FY2025 to 0.8% in FY2026 shows a sharp operating recovery, but not a return to the stronger FY2024 level. With gross margin narrowing to 31.7% while revenue stayed nearly flat, the improvement appears tied to expenses below gross profit rather than stronger gross-profit economics.

Liabilities declined from $69.8M in FY2025 to $60.7M in FY2026, reducing claims against the asset base. The current ratio improved from 1.7x to 1.8x, indicating better short-term coverage, while debt-to-equity remained elevated versus FY2024.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 37 / 100
Financial Health Score 37/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of AstroNova, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
29

AstroNova, Inc. has an operating margin of 0.8%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 29/100, suggesting thin profitability after operating expenses. This is up from -5.7% the prior year.

Growth
33

AstroNova, Inc.'s revenue declined 0.5% year-over-year, from $151.3M to $150.5M. This contraction results in a growth score of 33/100.

Leverage
28

AstroNova, Inc. has elevated debt relative to equity (D/E of 0.24), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 28/100, reflecting increased financial risk.

Liquidity
54

AstroNova, Inc.'s current ratio of 1.84 indicates adequate short-term liquidity, earning a score of 54/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
50

AstroNova, Inc. has a free cash flow margin of 7.6%, earning a moderate score of 50/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
27

AstroNova, Inc. posts a -3.1% return on equity (ROE), meaning it loses $3 for every $100 of shareholders' equity. This results in a returns score of 27/100. This is up from -19.1% the prior year.

Altman Z-Score Safe
4.13

AstroNova, Inc. scores 4.13, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($227.3M) relative to total liabilities ($60.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

AstroNova, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed
N/A

AstroNova, Inc. reported a net loss of $2.4M while generating $11.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
0.80x

AstroNova, Inc. earns $0.80 in operating income for every $1 of interest expense ($1.2M vs $1.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$39.4M
YoY+4.4%
QoQ+4.9%
5Y CAGR+7.0%
10Y CAGR+5.5%

AstroNova, Inc. generated $39.4M in revenue in Q1 2027. This represents an increase of 4.4% from the same quarter a year earlier. Against the prior quarter it is up 4.9%.

EBITDA
$2.7M
YoY+47.4%
QoQ+86.7%
5Y CAGR-1.2%

AstroNova, Inc.'s EBITDA was $2.7M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 47.4% from the same quarter a year earlier. Against the prior quarter it is up 86.7%.

Net Income
$653K
YoY+273.7%
QoQ+157.5%
5Y CAGR+122.4%
10Y CAGR-8.3%

AstroNova, Inc. reported $653K in net income in Q1 2027. This represents an increase of 273.7% from the same quarter a year earlier. Against the prior quarter it is up 157.5%.

EPS (Diluted)
$0.08
YoY+260.0%
QoQ+153.3%
10Y CAGR-8.8%

AstroNova, Inc. earned $0.08 per diluted share (EPS) in Q1 2027. This represents an increase of 260.0% from the same quarter a year earlier. Against the prior quarter it is up 153.3%.

Cash & Balance Sheet

Free Cash Flow
$3.0M
YoY-31.1%
QoQ-15.5%
5Y CAGR+13.3%

AstroNova, Inc. generated $3.0M in free cash flow in Q1 2027, representing cash available after capex. This represents a decrease of 31.1% from the same quarter a year earlier. Against the prior quarter it is down 15.5%.

Cash & Debt
$4.7M
YoY-12.7%
QoQ+14.8%
5Y CAGR-13.4%
10Y CAGR-9.9%

AstroNova, Inc. held $4.7M in cash against $16.2M in long-term debt as of Q1 2027.

Shares Outstanding
8M
YoY+1.7%
QoQ+0.5%
5Y CAGR+1.5%
10Y CAGR+0.7%

AstroNova, Inc. had 8M shares outstanding in Q1 2027. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 0.5%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin
36.6%
YoY+5.0pp
QoQ+10.4pp
5Y change+1.9pp
10Y change-7.2pp

AstroNova, Inc.'s gross margin was 36.6% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 5.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.4 percentage points.

Operating Margin
4.0%
YoY+2.5pp
QoQ+3.8pp
5Y change+2.5pp
10Y change-7.2pp

AstroNova, Inc.'s operating margin was 4.0% in Q1 2027, reflecting core business profitability. This is up 2.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Net Margin
1.7%
YoY+2.7pp
QoQ+4.7pp
5Y change+1.6pp
10Y change-5.1pp

AstroNova, Inc.'s net profit margin was 1.7% in Q1 2027, showing the share of revenue converted to profit. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.7 percentage points.

Return on Equity
0.8%
YoY+1.3pp
QoQ+2.3pp
5Y change+0.8pp
10Y change-1.4pp

AstroNova, Inc.'s ROE was 0.8% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.3 percentage points.

Capital Allocation

R&D Spending
$1.8M
YoY+18.3%
QoQ+1.3%
5Y CAGR+5.1%
10Y CAGR+1.5%

AstroNova, Inc. invested $1.8M in research and development in Q1 2027. This represents an increase of 18.3% from the same quarter a year earlier. Against the prior quarter it is up 1.3%.

Capital Expenditures
$36K
YoY-40.0%
QoQ-74.1%
5Y CAGR-47.5%

AstroNova, Inc. invested $36K in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 40.0% from the same quarter a year earlier. Against the prior quarter it is down 74.1%.

Share Buybacks

Not reported for Q1 2027.

ALOT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALOT quarterly income statement
MetricQ1'2710-QQ4'2610-QQ3'2610-KQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ1'2510-Q
Revenue$39.4M+4.4%$37.5M-7.1%$39.2M-3.4%$36.1M$37.7M+14.4%$40.4M+2.1%$40.5M+8.0%$33.0M-6.9%
Cost of Revenue$24.9M-3.2%$27.7M+3.7%$25.0M-4.7%$24.5M$25.8M+22.7%$26.7M-0.9%$26.2M+15.1%$21.0M-8.9%
Gross Profit$14.4M+20.7%$9.9M-28.2%$14.2M-0.9%$11.6M$12.0M-0.2%$13.7M+8.6%$14.3M-3.1%$12.0M-3.3%
R&D Expenses$1.8M+18.3%$1.8M-3.1%$1.9M+34.4%$1.6M$1.5M-4.6%$1.8M+40.4%$1.4M-16.1%$1.6M-10.3%
SG&A Expenses$5.4M+26.3%$2.0M-48.7%$5.1M0.0%$5.0M$4.2M+26.1%$3.9M+57.3%$5.1M+87.3%$3.4M+7.7%
Operating Income$1.6M+173.6%$56K-95.6%$1.3M+21.3%-$708K$571K-57.6%$1.3M-67.7%$1.1M-77.0%$1.3M-7.9%
EBITDA$2.7M+47.4%$1.5M-42.7%$2.2M-7.4%$492K$1.9M-17.5%$2.6M-49.0%$2.4M-58.0%$2.3M-10.3%
Interest Expense$400K0.0%$429K-14.2%$300K-46.4%$371K$400K-17.0%$500K-35.7%$560K-11.1%$482K-21.6%
Income Tax$196K+161.3%$347K+920.6%-$128K-149.0%-$454K$75K+117.3%$34K-94.7%$261K-72.5%-$434K-342.5%
Net Income$653K+273.7%-$1.1M-572.9%$378K+221.5%-$1.2M-$376K-131.8%$240K-91.1%-$311K-111.3%$1.2M+39.3%
EPS (Basic)$0.09+280.0%-$0.15-600.0%$0.05+225.0%-$0.16-$0.05-131.3%$0.03-91.7%-$0.04-110.8%$0.16+33.3%
EPS (Diluted)$0.08+260.0%-$0.15-600.0%$0.05+225.0%-$0.16-$0.05-133.3%$0.03-91.7%-$0.04-110.8%$0.15+36.4%
Diluted Shares (Avg)8M+2.8%N/A8M+2.4%8M8M-0.9%8M8M+0.4%8M+2.4%

ALOT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALOT quarterly balance sheet
MetricQ1'2710-QQ4'2610-QQ3'2610-KQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ1'2510-Q
Total Assets$139.9M-7.0%$137.6M-17.4%$140.8M-16.7%$143.1M$150.3M+18.7%$166.5M+24.9%$169.0M+25.9%$126.6M-9.0%
Current Assets$74.7M-8.0%$70.7M-15.2%$74.1M-10.7%$75.2M$81.2M+15.5%$83.4M+8.8%$83.1M+8.0%$70.3M-12.7%
Cash & Equivalents$4.7M-12.7%$4.1M-8.1%$3.6M-25.2%$3.9M$5.4M+34.2%$4.4M-2.1%$4.8M-0.1%$4.0M-26.3%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$43.9M-14.6%$43.3M-10.9%$45.1M-10.8%$48.4M$51.5M+13.9%$48.6M+4.7%$50.6M+7.6%$45.2M-15.0%
Accounts Receivable$21.6M+1.2%$19.0M-24.5%$20.4M-13.0%$18.5M$21.4M+19.6%$25.2M+9.1%$23.4M+6.6%$17.9M-7.4%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$17.2M+13.2%$17.4M-31.4%$17.1M-32.5%$15.3M$15.2M+4.8%$25.3M+73.1%$25.4M+75.7%$14.5M-1.5%
Total Liabilities$62.3M-15.5%$60.7M-18.3%$64.0M-17.2%$67.4M$73.8M+108.4%$74.3M+72.9%$77.3M+63.3%$35.4M-34.1%
Current Liabilities$42.4M-12.9%$38.4M-15.6%$40.6M-8.7%$43.9M$48.6M+112.3%$45.5M+52.8%$44.5M+32.1%$22.9M-38.8%
Non-Current Liabilities$20.0M-20.5%$22.3M-22.5%$23.3M-28.8%$23.5M$25.1M+101.3%$28.8M+118.1%$32.7M+140.5%$12.5M-23.4%
Long-Term Debt$16.2M-18.8%$18.3M-13.2%$19.0M-16.3%$18.6M$20.0M+114.1%$21.1M+109.7%$22.7M+125.9%$9.3M-20.0%
Total Equity$77.5M+1.3%$76.9M-16.6%$76.9M-16.2%$75.8M$76.6M-16.1%$92.2M+2.1%$91.8M+5.6%$91.2M+6.7%
Retained Earnings$47.7M-2.7%$47.0M-27.7%$48.1M-25.6%$47.8M$49.0M-24.7%$65.0M+1.7%$64.7M+5.9%$65.0M+8.4%

ALOT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALOT quarterly cash flow statement
MetricQ1'2710-QQ4'2610-QQ3'2610-KQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ1'2510-Q
Operating Cash Flow$3.0M-31.3%$3.7M+177.5%$3.4M+2011.7%$249K$4.4M-36.3%-$4.7M-173.5%$162K-86.3%$6.9M+161.3%
Depreciation & Amortization$1.2M-8.4%$1.4M+6.1%$900K-30.8%$1.2M$1.3M+41.6%$1.3M+17.3%$1.3M+30.0%$911K-13.6%
Stock-Based Compensation$389K+27.1%N/A$754K+56.8%$499K$306K-5.8%$353K$481K+54.7%$325K-8.7%
Capital Expenditures$36K-40.0%$139K-45.7%$86K-74.6%$47K$60K-87.8%$256K-36.6%$338K-56.9%$492K+925.0%
Free Cash Flow$3.0M-31.1%$3.5M+170.7%$3.3M+1994.9%$202K$4.3M-32.4%-$5.0M-182.6%-$176K-144.1%$6.4M+147.2%
Investing Cash Flow-$36K+40.0%-$126K-109.2%$14K+100.1%-$47K-$60K+87.8%$1.4M+237.6%-$21.1M-2583.7%-$492K-925.0%
Financing Cash Flow-$2.2M+46.9%-$3.1M-205.4%-$3.8M-117.5%-$1.7M-$4.2M+39.3%$3.0M+142.4%$21.5M+16932.0%-$7.0M-489.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ALOT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ALOT quarterly financial ratios
MetricQ1'2710-QQ4'2610-QQ3'2610-KQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ1'2510-Q
Gross Margin36.6%+5.0pp26.3%-7.7pp36.3%+0.9pp32.2%31.7%-4.6pp33.9%+2.0pp35.3%-4.0pp36.3%+1.4pp
Operating Margin4.0%+2.5pp0.1%-3.0pp3.3%+0.7pp-2.0%1.5%-2.6pp3.1%-6.8pp2.6%-9.7pp4.1%0.0pp
Net Margin1.7%+2.7pp-3.0%-3.6pp1.0%+1.7pp-3.4%-1.0%-4.6pp0.6%-6.3pp-0.8%-8.1pp3.6%+1.2pp
Return on Equity0.8%+1.3pp-1.5%-1.7pp0.5%+0.8pp-1.6%-0.5%-1.8pp0.3%-2.7pp-0.3%-3.5pp1.3%+0.3pp
Return on Assets0.5%+0.7pp-0.8%-1.0pp0.3%+0.5pp-0.9%-0.3%-1.2pp0.1%-1.9pp-0.2%-2.2pp0.9%+0.3pp
Current Ratio1.76+0.1x1.840.0x1.820.0x1.711.67-1.4x1.83-0.7x1.87-0.4x3.07+0.9x
Debt-to-Equity0.21-0.1x0.240.0x0.250.0x0.240.26+0.2x0.23+0.1x0.25+0.1x0.100.0x
Asset Turnover0.280.0x0.270.0x0.280.0x0.250.250.0x0.24-0.1x0.240.0x0.260.0x
FCF Margin7.6%-3.9pp9.4%+21.8pp8.5%+8.9pp0.6%11.5%-8.0pp-12.4%-27.6pp-0.4%-1.5pp19.4%+12.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
AstroNova, Inc. ALOT FY2026 $150.5M -$2.4M -1.6% $227.3M 37/100
Planet Image International Limited YIBO FY2025 $155.2M -$8.3M -5.3% $64.0M 41/100
Quantum Corporation QMCO FY2026 $279.6M -$101.0M -36.1% $1.2B 10/100
AgEagle Aerial Systems, Inc. UAVS FY2025 $12.8M -$5.3M -41.2% $54.2M 48/100
One Stop Systems, Inc. OSS FY2025 $32.2M $5.1M 15.8% $198.3M 45/100
3D Systems Corporation DDD FY2025 $386.9M $29.9M 7.7% $566.6M 33/100

Frequently Asked Questions

What is AstroNova, Inc.'s annual revenue?

AstroNova, Inc. (ALOT) reported $150.5M in total revenue for fiscal year 2026. This represents a -0.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is AstroNova, Inc.'s revenue growing?

AstroNova, Inc. (ALOT) revenue declined by 0.5% year-over-year, from $151.3M to $150.5M in fiscal year 2026.

Is AstroNova, Inc. profitable?

No, AstroNova, Inc. (ALOT) reported a net income of -$2.4M in fiscal year 2026, with a net profit margin of -1.6%.

AstroNova, Inc. (ALOT) reported diluted earnings per share of -$0.31 for fiscal year 2026. This represents a 83.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

AstroNova, Inc. (ALOT) had EBITDA of $6.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, AstroNova, Inc. (ALOT) had $4.1M in cash and equivalents against $18.3M in long-term debt.

AstroNova, Inc. (ALOT) had a gross margin of 31.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

AstroNova, Inc. (ALOT) had an operating margin of 0.8% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

AstroNova, Inc. (ALOT) had a net profit margin of -1.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

AstroNova, Inc. (ALOT) has a return on equity of -3.1% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

AstroNova, Inc. (ALOT) generated $11.4M in free cash flow during fiscal year 2026. This represents a 209.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

AstroNova, Inc. (ALOT) generated $11.7M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

AstroNova, Inc. (ALOT) had $137.6M in total assets as of fiscal year 2026, including both current and long-term assets.

AstroNova, Inc. (ALOT) invested $332K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

AstroNova, Inc. (ALOT) invested $6.8M in research and development during fiscal year 2026.

AstroNova, Inc. (ALOT) had 8M shares outstanding as of fiscal year 2026.

AstroNova, Inc. (ALOT) had a current ratio of 1.84 as of fiscal year 2026, which is generally considered healthy.

AstroNova, Inc. (ALOT) had a debt-to-equity ratio of 0.24 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

AstroNova, Inc. (ALOT) had a return on assets of -1.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

AstroNova, Inc. (ALOT) has an Altman Z-Score of 4.13, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

AstroNova, Inc. (ALOT) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

AstroNova, Inc. (ALOT) reported a net loss of $2.4M while generating $11.7M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

AstroNova, Inc. (ALOT) has an interest coverage ratio of 0.80x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

AstroNova, Inc. (ALOT) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top